Disclosed herein are borazine, borate, and azaborinine compounds and compositions, methods of making said compounds and compositions, and methods of forming aromatic difluorocarbon compounds and difluorocarbon compounds.

Disclosed herein are borazine, borate, and azaborinine compounds and compositions, methods of making said compounds and compositions, and methods of forming aromatic difluorocarbon compounds and difluorocarbon compounds.

To provide a novel boron-containing compound. A compound represented by the following formula: wherein black circle represents B, white circles represent B—H; —R.sup.1 represents —(CH.sub.2)n-X.sup.1—R.sup.3 (n represents an integer of 0 to 6; X.sup.1 represents O, S, NH, S—S, O—CO, NHCO or SCO, or does not exist; R.sup.3 represents C.sub.6-C.sub.20 alkyl, hydroxy C.sub.6-C.sub.20 alkyl, amino C.sub.6-C.sub.20 alkyl, azido C.sub.6-C.sub.20 alkyl, hydroxycarbonyl C.sub.6-C.sub.20 alkyl, or the like), or a group having a repeating sequence of —(CH.sub.2).sub.2—O— 3 times or more and 10 times or less and having a methyl group or an ethyl group at the end on the oxygen atom side; and —R.sup.2 is —(CH.sub.2)m-X.sup.2—R.sup.4 (m represents an integer from 0 to 8; X.sup.2 represents O, S, NH, S—S, O—CO, NHCO or SCO, or does not exist; and R.sup.4 represents a tumor recognition moiety), or does not exist are prepared and used. ##STR00001##

To provide a novel boron-containing compound. A compound represented by the following formula: wherein black circle represents B, white circles represent B—H; —R.sup.1 represents —(CH.sub.2)n-X.sup.1—R.sup.3 (n represents an integer of 0 to 6; X.sup.1 represents O, S, NH, S—S, O—CO, NHCO or SCO, or does not exist; R.sup.3 represents C.sub.6-C.sub.20 alkyl, hydroxy C.sub.6-C.sub.20 alkyl, amino C.sub.6-C.sub.20 alkyl, azido C.sub.6-C.sub.20 alkyl, hydroxycarbonyl C.sub.6-C.sub.20 alkyl, or the like), or a group having a repeating sequence of —(CH.sub.2).sub.2—O— 3 times or more and 10 times or less and having a methyl group or an ethyl group at the end on the oxygen atom side; and —R.sup.2 is —(CH.sub.2)m-X.sup.2—R.sup.4 (m represents an integer from 0 to 8; X.sup.2 represents O, S, NH, S—S, O—CO, NHCO or SCO, or does not exist; and R.sup.4 represents a tumor recognition moiety), or does not exist are prepared and used. ##STR00001##

The present invention includes novel compounds having a fused carborane ring that may be used as materials for OLEDs, such as charge transporters or hosts.

The present invention includes novel compounds having a fused carborane ring that may be used as materials for OLEDs, such as charge transporters or hosts.

A catalyst represented by General Formula (1) below: ##STR00001## where in the General Formula (1), R.sup.1 to R.sup.14 each independently represent a hydrogen atom or a substituent.

A catalyst represented by General Formula (1) below: ##STR00001## where in the General Formula (1), R.sup.1 to R.sup.14 each independently represent a hydrogen atom or a substituent.

Compounds, pharmaceutical formulations, and methods of treating anti-inflammatory conditions are disclosed.

Compounds, pharmaceutical formulations, and methods of treating anti-inflammatory conditions are disclosed.